Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence

Rivka M Lim1, Mark E J Woolhouse2,3, Takafira Mduluza4

  • 1Institute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.

Insights

Schistosomiasis prevalence in school-aged children (SAC) can predict infection levels in preschool-aged children (PSAC). This finding aids in targeting schistosomiasis treatment programs for young children, supporting global elimination goals.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The World Health Organization aims to eliminate schistosomiasis by 2025, requiring treatment of preschool-aged children (PSAC).
  • Quantifying schistosomiasis infection in PSAC is crucial for effective treatment strategies but remains a challenge.
  • Existing methods for assessing infection in PSAC need validation and simplification for public health programs.

Purpose of the Study:

  • To investigate the relationship between schistosomiasis infection levels in PSAC and school-aged children (SAC).
  • To determine if SAC infection prevalence can serve as a proxy for estimating PSAC infection prevalence.
  • To inform schistosomiasis treatment program strategies for PSAC in Africa.

Main Methods:

  • Systematic literature review of schistosomiasis prevalence studies in African PSAC and SAC.
  • PRISMA guidelines and SPIDER search strategy tool were employed for data collection.
  • Regression analysis was used to assess the correlation between PSAC and SAC infection levels, controlling for covariates.

Main Results:

  • A significant positive correlation was found between PSAC and SAC infection prevalence for both Schistosoma mansoni (r=0.812) and S. haematobium (r=0.786).
  • This relationship remained significant after accounting for diagnostic methods, treatment history, and geographical sub-region.
  • Regression models accurately classified over 90% of PSAC prevalence studies based on SAC data, irrespective of treatment history.

Conclusions:

  • Schistosomiasis prevalence in SAC is a reliable proxy for estimating infection levels in PSAC.
  • This finding supports the use of SAC prevalence data to guide and accelerate schistosomiasis treatment efforts in PSAC.
  • The study provides a practical approach to identify areas needing intensified PSAC treatment for schistosomiasis elimination.